glp-1 prescription reimbursement reporting requirements hr HRAs: A Smarter Way for Employers to Support Weight Loss Medications – EmpowerFlex Indications for GLP-1/GIP RA Summary

Scott Harris, M.D., will be discussing the promise of #GLP1/#Glucagon approaches in treating #MASH and #MASLD, as well as the importance of developing therapies tailored to the specific needs of patients with #obesity and/or #MASH

GLP-1 research tablet provides 25 x 7mg tablets of GLP-1 receptor agonist studied in preclinical models for incretin-pathway signaling, metabolic regulation, and energy-balance pathways

FDA Ozempic warning focuses on labeling for side effects like thyroid tumors, pancreatitis, and vision changes

Learn how Brandon, Trinity, and Westchase, FL, patients safely can administer Semaglutide and Tirzepatide for long term weight loss.

Suggested Use: For adult use only

The pricing adjustment, effective immediately, represents an early organizational response to []